Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 2
2022 9
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Relationship between Proclarix and the Aggressiveness of Prostate Cancer.
Campistol M, Triquell M, Regis L, Celma A, de Torres I, Semidey ME, Mast R, Mendez O, Planas J, Trilla E, Morote J. Campistol M, et al. Mol Diagn Ther. 2023 Jul;27(4):487-498. doi: 10.1007/s40291-023-00649-y. Epub 2023 Apr 20. Mol Diagn Ther. 2023. PMID: 37081322
Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imaging.
Morote J, Pye H, Campistol M, Celma A, Regis L, Semidey M, de Torres I, Mast R, Planas J, Santamaria A, Trilla E, Athanasiou A, Singh S, Heavey S, Stopka-Farooqui U, Freeman A, Haider A, Schiess R, Whitaker HC, Punwani S, Ahmed HU, Emberton M. Morote J, et al. Among authors: campistol m. BJU Int. 2023 Aug;132(2):188-195. doi: 10.1111/bju.15998. Epub 2023 Mar 21. BJU Int. 2023. PMID: 36855895
Comparison of Rotterdam and Barcelona Magnetic Resonance Imaging Risk Calculators for Predicting Clinically Significant Prostate Cancer.
Morote J, Borque-Fernando Á, Triquell M, Campistol M, Servian P, Abascal JM, Planas J, Méndez O, Esteban LM, Trilla E. Morote J, et al. Among authors: campistol m. Eur Urol Open Sci. 2023 May 22;53:46-54. doi: 10.1016/j.euros.2023.03.013. eCollection 2023 Jul. Eur Urol Open Sci. 2023. PMID: 37441350 Free PMC article.
Stratifying the initial prostate cancer suspicion to avoid magnetic resonance exams by sequencing men according to serum prostate-specific antigen, digital rectal examination and the prostate-specific antigen density based on digital rectal prostate volume category.
Morote J, Triquell M, Campistol M, Abascal JM, Servian P, Trilla E. Morote J, et al. Among authors: campistol m. BJUI Compass. 2022 Dec 28;4(3):266-268. doi: 10.1002/bco2.211. eCollection 2023 May. BJUI Compass. 2022. PMID: 37025471 Free PMC article. No abstract available.
The Efficacy of Proclarix to Select Appropriate Candidates for Magnetic Resonance Imaging and Derived Prostate Biopsies in Men with Suspected Prostate Cancer.
Morote J, Campistol M, Celma A, Regis L, de Torres I, Semidey ME, Roche S, Mast R, Santamaría A, Planas J, Trilla E. Morote J, et al. Among authors: campistol m. World J Mens Health. 2022 Apr;40(2):270-279. doi: 10.5534/wjmh.210117. Epub 2021 Dec 27. World J Mens Health. 2022. PMID: 35021312 Free PMC article.
Improving the Early Detection of Clinically Significant Prostate Cancer in Men in the Challenging Prostate Imaging-Reporting and Data System 3 Category.
Morote J, Campistol M, Triquell M, Celma A, Regis L, de Torres I, Semidey ME, Mast R, Santamaria A, Planas J, Trilla E. Morote J, et al. Among authors: campistol m. Eur Urol Open Sci. 2022 Jan 23;37:38-44. doi: 10.1016/j.euros.2021.12.009. eCollection 2022 Mar. Eur Urol Open Sci. 2022. PMID: 35243388 Free PMC article.
14 results